TCL Archive Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision December 2, 2011
TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive Markup Completed On Senate Cancer Act Renewal; Waxman Agrees To $90 Million Centers Line Item May 2, 1980
TCL Archive “Projects For Special Donors” – ACS Considering Way To Raise Vast New Sums For Cancer Program March 31, 1978
